HIV Diagnostics – Point-of-Care and Decentralized Testing and Monitoring

In 2012, UNITAID today announced the largest yet investment in point-of-care and decentralized HIV diagnostic products.

Diagnostics are the gateway to HIV/AIDS care and treatment but there are still considerable barriers to access in resource-limited settings. Today, many diagnostics facilities are centralized and require highly trained staff and specialised infrastructure. Patients are often lost due to great distances between testing centres and home as well as delays in returning results. Diagnostics needs to be moved to the periphery and closer to the site of patient care ("point-of-care") so patients can get their results conveniently and quickly.

In 2011 UNITAID began mapping the market for HIV diagnostics, and later launched a call for new proposals focused on point-of-care diagnostics.  Following an Executive Board decision in 2012, UNITAID expects to commit more than US$ 140 million to support the introduction and scale up of innovative new HIV diagnostics through a number of projects and initiatives.

These projects are complemented by a UNITAID-funded "market entry initiative". This work aims to support developers during final field validation, product registration and other late-stage commercialization steps to accelerate the launch on the market of needed products, and induce competition in the market.

Back to HIV/AIDS main page.